In a significant/important/landmark development for the treatment of spinal muscular atrophy (SMA), the Delhi High Court has upheld/approved/supported the regulatory approval/permission/sanction for the drug risdiplam https://haarisvmmj301477.blog-gold.com/50983480/the-delhi-high-court-confirms-government-sanction-for-risdiplam-in-india